Model innovation in Parkinson's disease drug development: linking Quantitative Systems Pharmacology to the patient voice

被引：0
|
作者：
Barrett, J.
Piccoli, B.
Muller, M.
Barrett, K.
Goncharov, D.
Kaddi, C.
Azer, K.
Romero, K.
Stephenson, D.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
287
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [31] A review of interactive voice response systems in Parkinson's Disease
    Domingues, J.
    Guerreiro, T.
    Branco, D.
    Rodrigues, A.
    Bouca-Machado, R.
    Ferreira, J.
    MOVEMENT DISORDERS, 2019, 34 : S283 - S284
  • [32] Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology
    Lacroix, Clemence
    Soeiro, Thomas
    Le Marois, Marguerite
    Guilhaumou, Romain
    Casse-Perrot, Catherine
    Jouve, Elisabeth
    Rohl, Claas
    Belzeaux, Raoul
    Micallef, Joelle
    Blin, Olivier
    THERAPIE, 2021, 76 (02): : 111 - 119
  • [33] Quantitative Systems Pharmacology: Modelling and simulating drug action in health and disease
    Niederer, Steven
    Sher, Anna
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2018, 139 : 1 - 2
  • [34] Connecting Neuronal Cell Protective Pathways and Drug Combinations in a Huntington’s Disease Model through the Application of Quantitative Systems Pharmacology
    Fen Pei
    Hongchun Li
    Mark J. Henderson
    Steven A. Titus
    Ajit Jadhav
    Anton Simeonov
    Murat Can Cobanoglu
    Seyed H. Mousavi
    Tongying Shun
    Lee McDermott
    Prema Iyer
    Michael Fioravanti
    Diane Carlisle
    Robert M. Friedlander
    Ivet Bahar
    D. Lansing Taylor
    Timothy R. Lezon
    Andrew M. Stern
    Mark E. Schurdak
    Scientific Reports, 7
  • [35] Connecting Neuronal Cell Protective Pathways and Drug Combinations in a Huntington's Disease Model through the Application of Quantitative Systems Pharmacology
    Pei, Fen
    Li, Hongchun
    Henderson, Mark J.
    Titus, Steven A.
    Jadhav, Ajit
    Simeonov, Anton
    Cobanoglu, Murat Can
    Mousavi, Seyed H.
    Shun, Tongying
    McDermott, Lee
    Iyer, Prema
    Fioravanti, Michael
    Carlisle, Diane
    Friedlander, Robert M.
    Bahar, Ivet
    Taylor, D. Lansing
    Lezon, Timothy R.
    Stern, Andrew M.
    Schurdak, Mark E.
    SCIENTIFIC REPORTS, 2017, 7
  • [36] Drug development in Parkinson's disease: From emerging molecules to innovative drug delivery systems
    Garbayo, E.
    Ansorena, E.
    Blanco-Prieto, M. J.
    MATURITAS, 2013, 76 (03) : 272 - 278
  • [37] Creating a Roadmap to Quantitative Systems Pharmacology-Informed Rare Disease Drug Development: A Workshop Report
    Bai, Jane P. F.
    Stinchcomb, Audra L.
    Wang, Jie
    Earp, Justin
    Stern, Sydney
    Schuck, Robert N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (02) : 201 - 205
  • [38] DEVELOPMENT OF A QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL OF INFLAMMATORY BOWEL DISEASES
    Rogers, K.
    Nayak, S.
    Ahmad, A.
    Martin, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S85 - S85
  • [39] Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug Development
    Liping Zhang
    Marc Pfister
    Bernd Meibohm
    The AAPS Journal, 2008, 10 : 552 - 559
  • [40] Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug Development
    Zhang, Liping
    Pfister, Marc
    Meibohm, Bernd
    AAPS JOURNAL, 2008, 10 (04): : 552 - 559
12345